A new way to treat acute pain

Could sodium channel blockers replace opioid pain medications?

The U.S. Food and Drug Administration (FDA) recently approved Journax™ (suzetrigine) for moderate to-severe acute pain. This is the first approved drug in a class of medications known as sodium channel blockers. It offers a new, but pricier, option for acute pain management.

If this medication gains additional indications for chronic pain, it will significantly affect future spending. Get details on how this newly approved painkilling drug is offering prescribers a long-waited alternative to opioid pain medications and what it means for plan sponsors.